It provides validated, integrated and evaluated information on all aspects of drug development, from first patent application to launch or discontinuation.

Subscribers include most major pharmaceutical and biotechnology companies the world over. In addition, more and more companies servicing the pharmaceutical and biotechnology sector are subscribing. Chemical companies, CROs, consultants and media providers find IDdb3 invaluable in locating lucrative new business partners.

Find out why your competitors and potential business partners, working in the following areas, find it such an invaluable business tool:

• Licensing
• Strategic planning
• Discovery research
• Clinical development
• Business development
• Knowledge management
• Marketing and market research